Therapeutic approaches targeting molecular signaling pathways common to diabetes, lung diseases and cancer
R Raguraman, A Srivastava, A Munshi… - Advanced drug delivery …, 2021 - Elsevier
Diabetes mellitus (DM), is the most common metabolic disease and is characterized by
sustained hyperglycemia. Accumulating evidences supports a strong association between …
sustained hyperglycemia. Accumulating evidences supports a strong association between …
MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal SMO to trigger Hedgehog pathway
Y Xia, L Zhen, H Li, S Wang, S Chen, C Wang… - Cell Death & …, 2021 - nature.com
Hepatocellular carcinoma (HCC), commonly caused by liver fibrosis, is a global challenge
with high morbidity. Activation of hepatic stellate cells (HSCs) contributes to hepatic fibrosis …
with high morbidity. Activation of hepatic stellate cells (HSCs) contributes to hepatic fibrosis …
IL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells
K Zhang, W Hu, F Li, C Wen, L Zhou, L Zhang… - British Journal of …, 2024 - nature.com
Abstract Background Cancer stem cells (CSCs) induce therapeutic resistance and may be
an important barrier to cancer immunotherapy. Chimeric antigen receptor T (CAR-T) cell …
an important barrier to cancer immunotherapy. Chimeric antigen receptor T (CAR-T) cell …
Polyethylenimine-Modified Bombyx mori Silk Fibroin as a Delivery Carrier of the ING4-IL-24 Coexpression Plasmid
L Niu, G Chen, Y Feng, X Liu, P Pan, L Huang, Y Guo… - Polymers, 2021 - mdpi.com
One of the major challenges for lung cancer gene therapy is to find a gene delivery vector
with high efficiency and low toxicity. In this study, low-molecular-weight polyethyleneimine …
with high efficiency and low toxicity. In this study, low-molecular-weight polyethyleneimine …
Interleukin 24: signal transduction pathways
S Smith, S Lopez, A Kim, J Kasteri, E Olumuyide… - Cancers, 2023 - mdpi.com
Simple Summary Interleukin 24 is a pleiotropic immunomodulatory cytokine. Numerous
studies have shown that enhancing or inhibiting the expression of Interleukin 24 has a …
studies have shown that enhancing or inhibiting the expression of Interleukin 24 has a …
Positive GLI1/INHBA feedback loop drives tumor progression in gastric cancer
J Sun, W Zhu, M Luan, Y Xing, Z Feng, J Zhu… - Cancer …, 2024 - Wiley Online Library
GLI1, a key transcription factor of the Hedgehog (Hh) signaling pathway, plays an important
role in the development of cancer. However, the function and mechanisms by which GLI1 …
role in the development of cancer. However, the function and mechanisms by which GLI1 …
Systemic multi-omics analysis reveals amplified P4HA1 gene associated with prognostic and hypoxic regulation in breast cancer
M Murugesan, K Premkumar - Frontiers in Genetics, 2021 - frontiersin.org
Breast cancer (BC) is a common malignant tumor in females around the world. While
multimodality therapies exist, the mortality rate remains high. The hypoxic condition was one …
multimodality therapies exist, the mortality rate remains high. The hypoxic condition was one …
[HTML][HTML] Glioma-associated oncogene homolog 1 stimulates FOXP3 to promote non-small cell lung cancer stemness
H Qi, W Li, J Zhang, J Chen, J Peng, Y Liu… - American Journal of …, 2020 - ncbi.nlm.nih.gov
Glioma-associated oncogene homolog 1 (GLI1), an oncogenic molecule in non-small cell
lung cancer (NSCLC), promotes the growth of NSCLC by enhancing lung cancer stem cells …
lung cancer (NSCLC), promotes the growth of NSCLC by enhancing lung cancer stem cells …
[HTML][HTML] A DNA Replication Stress-Based Prognostic Model for Lung Adenocarcinoma
S Shi, G Wen, C Lei, J Chang, X Yin, X Liu… - Acta Naturae …, 2023 - cyberleninka.ru
Tumor cells endure continuous DNA replication stress, which opens the way to cancer
development. Despite previous research, the prognostic implications of DNA replication …
development. Despite previous research, the prognostic implications of DNA replication …
[HTML][HTML] UC2288 induces cell apoptosis of nasopharyngeal carcinoma cells via inhibiting EGFR/ERK pathway
R Liang, X Zhu - Journal of Cancer, 2021 - ncbi.nlm.nih.gov
Radiotherapy and chemotherapy are the standard care for patients with nasopharyngeal
carcinoma (NPC). These treatments cause some severe toxicity and about 30% of patients …
carcinoma (NPC). These treatments cause some severe toxicity and about 30% of patients …